Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15049991rdf:typepubmed:Citationlld:pubmed
pubmed-article:15049991lifeskim:mentionsumls-concept:C0025266lld:lifeskim
pubmed-article:15049991lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:15049991lifeskim:mentionsumls-concept:C0229986lld:lifeskim
pubmed-article:15049991lifeskim:mentionsumls-concept:C0694643lld:lifeskim
pubmed-article:15049991lifeskim:mentionsumls-concept:C2348756lld:lifeskim
pubmed-article:15049991pubmed:issue6lld:pubmed
pubmed-article:15049991pubmed:dateCreated2004-3-30lld:pubmed
pubmed-article:15049991pubmed:abstractTextTo determine the regimen that would most effectively maintain serum testosterone concentrations in treated hypogonadal men within the normal reference range of 3-11.4 microg/L.lld:pubmed
pubmed-article:15049991pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15049991pubmed:languageenglld:pubmed
pubmed-article:15049991pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15049991pubmed:citationSubsetIMlld:pubmed
pubmed-article:15049991pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15049991pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15049991pubmed:statusMEDLINElld:pubmed
pubmed-article:15049991pubmed:monthAprlld:pubmed
pubmed-article:15049991pubmed:issn1464-4096lld:pubmed
pubmed-article:15049991pubmed:authorpubmed-author:MeikleA WAWlld:pubmed
pubmed-article:15049991pubmed:authorpubmed-author:HoffmanA RARlld:pubmed
pubmed-article:15049991pubmed:authorpubmed-author:MatthiasDDlld:pubmed
pubmed-article:15049991pubmed:issnTypePrintlld:pubmed
pubmed-article:15049991pubmed:volume93lld:pubmed
pubmed-article:15049991pubmed:ownerNLMlld:pubmed
pubmed-article:15049991pubmed:authorsCompleteYlld:pubmed
pubmed-article:15049991pubmed:pagination789-95lld:pubmed
pubmed-article:15049991pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:15049991pubmed:meshHeadingpubmed-meshheading:15049991...lld:pubmed
pubmed-article:15049991pubmed:meshHeadingpubmed-meshheading:15049991...lld:pubmed
pubmed-article:15049991pubmed:meshHeadingpubmed-meshheading:15049991...lld:pubmed
pubmed-article:15049991pubmed:meshHeadingpubmed-meshheading:15049991...lld:pubmed
pubmed-article:15049991pubmed:meshHeadingpubmed-meshheading:15049991...lld:pubmed
pubmed-article:15049991pubmed:meshHeadingpubmed-meshheading:15049991...lld:pubmed
pubmed-article:15049991pubmed:meshHeadingpubmed-meshheading:15049991...lld:pubmed
pubmed-article:15049991pubmed:meshHeadingpubmed-meshheading:15049991...lld:pubmed
pubmed-article:15049991pubmed:meshHeadingpubmed-meshheading:15049991...lld:pubmed
pubmed-article:15049991pubmed:meshHeadingpubmed-meshheading:15049991...lld:pubmed
pubmed-article:15049991pubmed:meshHeadingpubmed-meshheading:15049991...lld:pubmed
pubmed-article:15049991pubmed:year2004lld:pubmed
pubmed-article:15049991pubmed:articleTitleTransdermal testosterone gel: pharmacokinetics, efficacy of dosing and application site in hypogonadal men.lld:pubmed
pubmed-article:15049991pubmed:affiliationDepartment of Medicine, Division of Endocrinology, University of Utah School of Medicine, 615 Arapeen Drive, Suite 100, Salt Lake City, UT 84108, USA. Wayne.Meikle@hsc.utah.edulld:pubmed
pubmed-article:15049991pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15049991pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15049991pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15049991pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:15049991pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15049991lld:pubmed